PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2009 March; 10(1): 104–112.
Published online 2009 January 29. doi:  10.1208/s12249-008-9183-0
PMCID: PMC2663673
Studies on Mefenamic Acid Microparticles: Formulation, In Vitro Release, and In Situ Studies in Rats
Ferhan Sevgi,corresponding author1 Aysu Yurdasiper,1 Buket Kaynarsoy,1 Ezgi Turunç,2 Tamer Güneri,1 and Ayfer Yalçın2
1Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, 35100 Bornova, Izmir Turkey
2Department of Biochemistry, Faculty of Pharmacy, Ege University, 35100 Bornova, Izmir Turkey
Ferhan Sevgi, Phone: +90-232-3884000, Fax: +90-232-3885258, ferhan.sevgi/at/ege.edu.tr.
corresponding authorCorresponding author.
Received July 11, 2008; Accepted December 13, 2008.
Abstract
In this study, we investigated the in vitro characteristics of mefenamic acid (MA) microparticles as well as their effects on DNA damage. MA-loaded chitosan and alginate beads were prepared by the ionotropic gelation process. Microsponges containing MA and Eudragit RS 100 were prepared by quasi-emulsion solvent diffusion method. The microparticles were characterized in terms of particle size, surface morphology, encapsulation efficiency, and in vitro release profiles. Most of the formulation variables manifested an influence on the physical characteristics of the microparticles at varying degrees. We also studied the effects of MA, MA-loaded microparticles, and three different polymers on rat brain cortex DNA damage. Our results showed that DNA damage was higher in MA-loaded Eudragit microsponges than MA-loaded biodegradable chitosan or alginate microparticles.
Key words: DNA damage, kainic acid, mefenamic acid, microparticles
Articles from AAPS PharmSciTech are provided here courtesy of
American Association of Pharmaceutical Scientists